Loading
Obesity / Sham laser acupuncture / Overweight · Interventional Study
ClinicalTrials.gov · August 18, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned single-center randomized sham-controlled trial comparing active 810 nm laser acupuncture plus acupoint catgut embedding against sham laser plus embedding for obesity in 120 adults aged 20–65 years. No results are yet available in this registry record; the study is in pre-recruitment phase and designed to measure body weight change at 12 weeks as the primary outcome, with follow-up to 24 weeks.
Interventional, Randomized, Parallel, Quadruple masking, Treatment purpose. Obesity, Obesity, Abdominal, Overweight; age from 20 Years; to 65 Years. Intervention: Acupoint catgut embedding plus active laser acupuncture. Compared with: Acupoint catgut embedding plus sham laser acupuncture — Sham Comparator. n = 120. 1 site: Taiwan.
This is a planned single-center randomized sham-controlled trial comparing active 810 nm laser acupuncture plus acupoint catgut embedding against sham laser plus embedding for obesity in 120 adults aged 20–65 years. No results are yet available in this registry record; the study is in pre-recruitment phase and designed to measure body weight change at 12 weeks as the primary outcome, with follow-up to 24 weeks.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a planned trial registration with no results reported; the design is sound but enrollment has not yet begun, making it an early-stage study announcement rather than evidence of efficacy.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07770893). This is a study registration, not published results. Lead sponsor: Taipei City Hospital. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 120 participants (ESTIMATED). Conditions: Obesity, Obesity, Abdominal, Overweight. Interventions: PROCEDURE: Acupoint catgut embedding; DEVICE: Active laser acupuncture; DEVICE: Sham laser acupuncture; BEHAVIORAL: Dietary and exercise counseling. Primary outcome measures: Mean Change From Baseline in Body Weight at Week 12 , Baseline and Week 12. Brief summary: Acupoint catgut embedding and laser acupuncture have each been studied as treatments for obesity in adults, but the two have not been evaluated in combination, and few trials have measured anthropometric, biochemical, and blood pressure outcomes together. This single-center randomized sham-controlled trial plans to enroll 120 adults aged 20 to 65 years with obesity. All participants receive the same acupoint catgut embedding with poliglecaprone 25 absorbable suture at 15 acupoints, comprising 25 insertions, once every 2 weeks for 6 sessions over 12 weeks. Participants are randomly assigned in a 1:1 ratio to receive, immediately before each embedding session, either active 810 nm laser acupuncture or sham laser acupuncture delivered with a device that is identical in appearance, indicator light, and operating sound but emits no therapeutic energy. Both groups also receive standardized dietary and exercise counseling. Because the acupoint embedding regimen is identical in both groups and the groups differ only in whether the laser emits energy, the comparison estimates the incremental effect of laser acupuncture added to acupoint embedding. Participants are treated for 12 weeks and then followed for a further 12 weeks, to Week 24.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.